Streamlining Regulatory Compliance for AAV-Based Gene Therapies
Novel AAV vector design and capsid engineering carries important considerations throughout development, therefore a multidisciplinary approach must be undertaken to ensure regulatory approvals. Learn more about the regulatory pain points for developers and manufacturers and discover tips for meeting regulatory guidance for AAV-based gene therapies. Read this article to learn:
- When to talk to the regulatory teams
- The role of change management
- How to leverage collaboration across companies to solve challenges
Access the Article
Share a little information with us to access the entire article now.
Thank you for your interest in ! Access the PDF here.
Content you'll also find interesting